nodes	percent_of_prediction	percent_of_DWPC	metapath
Varenicline—CHRNA3—Bupropion—obesity	0.584	1	CbGbCtD
Varenicline—CHRFAM7A—ovarian follicle—obesity	0.0178	0.232	CbGeAlD
Varenicline—CHRNA7—ovarian follicle—obesity	0.0144	0.187	CbGeAlD
Varenicline—CHRNA4—autonomic nervous system—obesity	0.00727	0.0949	CbGeAlD
Varenicline—CHRNB2—islet of Langerhans—obesity	0.00317	0.0414	CbGeAlD
Varenicline—CHRNA4—hindbrain—obesity	0.00306	0.04	CbGeAlD
Varenicline—CHRNA3—respiratory system—obesity	0.0029	0.0379	CbGeAlD
Varenicline—CHRNB2—adrenal cortex—obesity	0.00251	0.0328	CbGeAlD
Varenicline—CHRFAM7A—respiratory system—obesity	0.00235	0.0306	CbGeAlD
Varenicline—CHRNB2—pituitary gland—obesity	0.00203	0.0265	CbGeAlD
Varenicline—CHRNB2—adipose tissue—obesity	0.00202	0.0264	CbGeAlD
Varenicline—CHRNA4—respiratory system—obesity	0.00187	0.0244	CbGeAlD
Varenicline—CHRNB2—adrenal gland—obesity	0.00181	0.0237	CbGeAlD
Varenicline—CHRNA3—adrenal gland—obesity	0.00176	0.023	CbGeAlD
Varenicline—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD4—obesity	0.00171	0.0296	CbGpPWpGaD
Varenicline—CHRNA6—Nicotine Activity on Dopaminergic Neurons—DRD2—obesity	0.00159	0.0276	CbGpPWpGaD
Varenicline—CHRNA3—endocrine gland—obesity	0.00152	0.0199	CbGeAlD
Varenicline—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD4—obesity	0.0015	0.0261	CbGpPWpGaD
Varenicline—CHRNA7—cardiovascular system—obesity	0.00145	0.019	CbGeAlD
Varenicline—CHRNA4—cardiovascular system—obesity	0.00143	0.0187	CbGeAlD
Varenicline—CHRNB2—liver—obesity	0.00142	0.0185	CbGeAlD
Varenicline—CHRNB2—Nicotine Activity on Dopaminergic Neurons—DRD2—obesity	0.0014	0.0243	CbGpPWpGaD
Varenicline—CHRFAM7A—endocrine gland—obesity	0.00123	0.0161	CbGeAlD
Varenicline—CHRNA7—digestive system—obesity	0.0012	0.0157	CbGeAlD
Varenicline—CHRNA4—digestive system—obesity	0.00119	0.0155	CbGeAlD
Varenicline—CHRNA7—adrenal gland—obesity	0.00115	0.015	CbGeAlD
Varenicline—CHRNA4—adrenal gland—obesity	0.00113	0.0148	CbGeAlD
Varenicline—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD4—obesity	0.00108	0.0188	CbGpPWpGaD
Varenicline—CHRNA3—Nicotine Activity on Dopaminergic Neurons—DRD2—obesity	0.00101	0.0175	CbGpPWpGaD
Varenicline—CHRNA7—endocrine gland—obesity	0.000996	0.013	CbGeAlD
Varenicline—CHRNB2—Circadian rythm related genes—CARTPT—obesity	0.000994	0.0173	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—RAI1—obesity	0.000994	0.0173	CbGpPWpGaD
Varenicline—CHRNA4—endocrine gland—obesity	0.000982	0.0128	CbGeAlD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	0.000972	0.0169	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PROX1—obesity	0.000886	0.0154	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—AGRP—obesity	0.000886	0.0154	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	0.000856	0.0149	CbGpPWpGaD
Varenicline—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD4—obesity	0.000837	0.0145	CbGpPWpGaD
Varenicline—CHRNA4—Nicotine Activity on Dopaminergic Neurons—DRD2—obesity	0.000779	0.0135	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GABRA6—obesity	0.000731	0.0127	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—GHRH—obesity	0.000672	0.0117	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—ACADM—obesity	0.000658	0.0114	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GABRA6—obesity	0.000643	0.0112	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000623	0.0108	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	0.000616	0.0107	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—GFPT1—obesity	0.000614	0.0107	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	0.000585	0.0102	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GABRA6—obesity	0.00056	0.00972	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GLUL—obesity	0.000521	0.00904	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000513	0.00892	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SLC9A3—obesity	0.000509	0.00884	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GABRA6—obesity	0.000493	0.00856	CbGpPWpGaD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA6—obesity	0.000477	0.00828	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NPY2R—obesity	0.000465	0.00809	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—MC3R—obesity	0.000465	0.00809	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GABRA6—obesity	0.000463	0.00805	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GLUL—obesity	0.000458	0.00796	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—ACADM—obesity	0.000449	0.0078	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GABRA6—obesity	0.00044	0.00763	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000426	0.0074	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GLUL—obesity	0.000399	0.00693	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—KCNMA1—obesity	0.000386	0.0067	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—SLC22A1—obesity	0.000384	0.00667	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.00038	0.00661	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—CPT1A—obesity	0.000367	0.00638	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—ACADM—obesity	0.000366	0.00636	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GABRA6—obesity	0.000358	0.00622	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—GCK—obesity	0.000358	0.00622	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GABRA6—obesity	0.000355	0.00616	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—GLUL—obesity	0.000351	0.0061	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000351	0.00609	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000347	0.00603	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TF—obesity	0.000342	0.00593	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—SLC22A1—obesity	0.000338	0.00587	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—KCNMA1—obesity	0.000337	0.00585	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GABRA6—obesity	0.000337	0.00585	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CLOCK—obesity	0.000337	0.00585	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GLUL—obesity	0.00033	0.00573	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000321	0.00558	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GLUL—obesity	0.000313	0.00544	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NTRK2—obesity	0.000312	0.00543	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CST3—obesity	0.000311	0.00539	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CPT1A—obesity	0.0003	0.00521	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	0.000297	0.00516	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—KCNMA1—obesity	0.000297	0.00515	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NAMPT—obesity	0.000294	0.00511	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—SLC22A1—obesity	0.000294	0.00511	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—ESR2—obesity	0.000288	0.00501	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000286	0.00497	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—BCHE—obesity	0.000283	0.00492	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—CRH—obesity	0.000282	0.0049	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GABRA6—obesity	0.000275	0.00477	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—NPS—obesity	0.000267	0.00464	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SREBF1—obesity	0.000262	0.00455	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SLC6A4—obesity	0.000262	0.00455	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—DRD1—obesity	0.000262	0.00455	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	0.000262	0.00455	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.00026	0.00452	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—SLC22A1—obesity	0.000259	0.0045	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GLUL—obesity	0.000255	0.00443	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—AR—obesity	0.000255	0.00442	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—GLUL—obesity	0.000253	0.00439	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—CPT1A—obesity	0.000251	0.00436	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—BCHE—obesity	0.00025	0.00433	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—GHRL—obesity	0.000249	0.00432	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—DRD4—obesity	0.000247	0.00428	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GCK—obesity	0.000245	0.00425	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—SLC22A1—obesity	0.000243	0.00423	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—ADIPOQ—obesity	0.000241	0.00418	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—GNB3—obesity	0.00024	0.00417	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.00024	0.00417	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—GLUL—obesity	0.00024	0.00417	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TF—obesity	0.000233	0.00405	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—BDNF—obesity	0.000233	0.00405	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—SLC22A1—obesity	0.000231	0.00401	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—DRD2—obesity	0.00023	0.00399	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—COMT—obesity	0.000227	0.00394	CbGpPWpGaD
Varenicline—CHRNA6—Transmission across Chemical Synapses—GNB3—obesity	0.000223	0.00388	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL10—obesity	0.000223	0.00387	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000219	0.00381	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—BCHE—obesity	0.000217	0.00377	CbGpPWpGaD
Varenicline—CHRNA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	0.000214	0.00372	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—KCNMA1—obesity	0.000214	0.00371	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NTRK2—obesity	0.000213	0.00371	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000212	0.00368	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—NR3C1—obesity	0.000206	0.00358	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—CPT1A—obesity	0.000205	0.00355	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—KCNMA1—obesity	0.000203	0.00352	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—COMT—obesity	0.000199	0.00347	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GCK—obesity	0.000199	0.00346	CbGpPWpGaD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—HTR2A—obesity	0.000197	0.00342	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—ESR2—obesity	0.000197	0.00342	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—GNB3—obesity	0.000197	0.00342	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—PPARGC1A—obesity	0.000196	0.0034	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—GLUL—obesity	0.000196	0.0034	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—BCHE—obesity	0.000191	0.00332	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TF—obesity	0.00019	0.0033	CbGpPWpGaD
Varenicline—CHRNB2—Circadian rythm related genes—SIRT1—obesity	0.00019	0.00329	CbGpPWpGaD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	0.000188	0.00327	CbGpPWpGaD
Varenicline—CHRNB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	0.000188	0.00327	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—SLC22A1—obesity	0.000188	0.00327	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—SLC22A1—obesity	0.000186	0.00324	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—BCHE—obesity	0.00018	0.00312	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000179	0.00311	CbGpPWpGaD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	0.000179	0.00311	CbGpPWpGaD
Varenicline—CHRNA7—Neuronal System—SLC22A1—obesity	0.000177	0.00307	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—AR—obesity	0.000174	0.00302	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NTRK2—obesity	0.000174	0.00302	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—COMT—obesity	0.000174	0.00302	CbGpPWpGaD
Varenicline—CHRNA6—Neuronal System—GNB3—obesity	0.000171	0.00297	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—BCHE—obesity	0.000171	0.00296	CbGpPWpGaD
Varenicline—CHRNA4—Neuronal System—KCNMA1—obesity	0.000165	0.00287	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—GNB3—obesity	0.000164	0.00285	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000164	0.00285	CbGpPWpGaD
Varenicline—Chills—Bupropion—obesity	0.000162	0.000573	CcSEcCtD
Varenicline—Vertigo—Sibutramine—obesity	0.000162	0.000573	CcSEcCtD
Varenicline—Syncope—Sibutramine—obesity	0.000161	0.000572	CcSEcCtD
Varenicline—Convulsion—Orlistat—obesity	0.000161	0.000571	CcSEcCtD
Varenicline—Arrhythmia—Bupropion—obesity	0.000161	0.000571	CcSEcCtD
Varenicline—CHRNA6—Transmission across Chemical Synapses—PRKCB—obesity	0.000161	0.00279	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—ESR2—obesity	0.000161	0.00279	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—BDNF—obesity	0.000159	0.00277	CbGpPWpGaD
Varenicline—Palpitations—Sibutramine—obesity	0.000159	0.000564	CcSEcCtD
Varenicline—Irritability—Topiramate—obesity	0.000158	0.000562	CcSEcCtD
Varenicline—Chest pain—Orlistat—obesity	0.000158	0.000561	CcSEcCtD
Varenicline—Myalgia—Orlistat—obesity	0.000158	0.000561	CcSEcCtD
Varenicline—Loss of consciousness—Sibutramine—obesity	0.000158	0.000561	CcSEcCtD
Varenicline—Mental disorder—Bupropion—obesity	0.000158	0.00056	CcSEcCtD
Varenicline—Urinary retention—Topiramate—obesity	0.000158	0.00056	CcSEcCtD
Varenicline—Anxiety—Orlistat—obesity	0.000158	0.00056	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—PPARA—obesity	0.000158	0.00274	CbGpPWpGaD
Varenicline—Mood swings—Topiramate—obesity	0.000157	0.000558	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000157	0.000558	CcSEcCtD
Varenicline—Cough—Sibutramine—obesity	0.000157	0.000557	CcSEcCtD
Varenicline—Malnutrition—Bupropion—obesity	0.000157	0.000556	CcSEcCtD
Varenicline—Discomfort—Orlistat—obesity	0.000156	0.000555	CcSEcCtD
Varenicline—Convulsion—Sibutramine—obesity	0.000156	0.000553	CcSEcCtD
Varenicline—Hypertension—Sibutramine—obesity	0.000155	0.000551	CcSEcCtD
Varenicline—Dry mouth—Orlistat—obesity	0.000155	0.000549	CcSEcCtD
Varenicline—Flatulence—Bupropion—obesity	0.000155	0.000548	CcSEcCtD
Varenicline—Dysgeusia—Bupropion—obesity	0.000154	0.000545	CcSEcCtD
Varenicline—Liver function test abnormal—Topiramate—obesity	0.000153	0.000543	CcSEcCtD
Varenicline—Arthralgia—Sibutramine—obesity	0.000153	0.000543	CcSEcCtD
Varenicline—Myalgia—Sibutramine—obesity	0.000153	0.000543	CcSEcCtD
Varenicline—Chest pain—Sibutramine—obesity	0.000153	0.000543	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—COMT—obesity	0.000153	0.00266	CbGpPWpGaD
Varenicline—Anxiety—Sibutramine—obesity	0.000153	0.000541	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL10—obesity	0.000152	0.00264	CbGpPWpGaD
Varenicline—Oedema—Orlistat—obesity	0.000152	0.000538	CcSEcCtD
Varenicline—Back pain—Bupropion—obesity	0.000152	0.000538	CcSEcCtD
Varenicline—Abdominal pain upper—Topiramate—obesity	0.000152	0.000538	CcSEcCtD
Varenicline—Discomfort—Sibutramine—obesity	0.000151	0.000537	CcSEcCtD
Varenicline—Hypokalaemia—Topiramate—obesity	0.000151	0.000536	CcSEcCtD
Varenicline—Muscle spasms—Bupropion—obesity	0.000151	0.000535	CcSEcCtD
Varenicline—Infection—Orlistat—obesity	0.000151	0.000535	CcSEcCtD
Varenicline—CHRNB2—Neuronal System—GNB3—obesity	0.000151	0.00262	CbGpPWpGaD
Varenicline—Breast disorder—Topiramate—obesity	0.00015	0.000532	CcSEcCtD
Varenicline—Dry mouth—Sibutramine—obesity	0.00015	0.000531	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—LEP—obesity	0.00015	0.0026	CbGpPWpGaD
Varenicline—Nervous system disorder—Orlistat—obesity	0.000149	0.000528	CcSEcCtD
Varenicline—Nasopharyngitis—Topiramate—obesity	0.000148	0.000526	CcSEcCtD
Varenicline—Vision blurred—Bupropion—obesity	0.000148	0.000524	CcSEcCtD
Varenicline—Skin disorder—Orlistat—obesity	0.000147	0.000523	CcSEcCtD
Varenicline—Tremor—Bupropion—obesity	0.000147	0.000521	CcSEcCtD
Varenicline—Gastritis—Topiramate—obesity	0.000147	0.000521	CcSEcCtD
Varenicline—Oedema—Sibutramine—obesity	0.000147	0.000521	CcSEcCtD
Varenicline—Hyperhidrosis—Orlistat—obesity	0.000147	0.00052	CcSEcCtD
Varenicline—Infection—Sibutramine—obesity	0.000146	0.000517	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—obesity	0.000146	0.00253	CbGpPWpGaD
Varenicline—Ill-defined disorder—Bupropion—obesity	0.000146	0.000516	CcSEcCtD
Varenicline—Anaemia—Bupropion—obesity	0.000145	0.000514	CcSEcCtD
Varenicline—Shock—Sibutramine—obesity	0.000145	0.000512	CcSEcCtD
Varenicline—Abdominal distension—Topiramate—obesity	0.000144	0.000512	CcSEcCtD
Varenicline—Agitation—Bupropion—obesity	0.000144	0.000511	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—SLC22A1—obesity	0.000144	0.0025	CbGpPWpGaD
Varenicline—Thrombocytopenia—Sibutramine—obesity	0.000144	0.00051	CcSEcCtD
Varenicline—CHRNA3—Transmission across Chemical Synapses—COMT—obesity	0.000144	0.0025	CbGpPWpGaD
Varenicline—Dysphagia—Topiramate—obesity	0.000144	0.000509	CcSEcCtD
Varenicline—Asthma—Topiramate—obesity	0.000144	0.000509	CcSEcCtD
Varenicline—Angioedema—Bupropion—obesity	0.000143	0.000508	CcSEcCtD
Varenicline—Tachycardia—Sibutramine—obesity	0.000143	0.000508	CcSEcCtD
Varenicline—Skin disorder—Sibutramine—obesity	0.000143	0.000506	CcSEcCtD
Varenicline—Hyperhidrosis—Sibutramine—obesity	0.000142	0.000504	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—AR—obesity	0.000142	0.00246	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—GNB3—obesity	0.000142	0.00246	CbGpPWpGaD
Varenicline—CHRNB2—Transmission across Chemical Synapses—PRKCB—obesity	0.000142	0.00246	CbGpPWpGaD
Varenicline—Malaise—Bupropion—obesity	0.000142	0.000502	CcSEcCtD
Varenicline—Vertigo—Bupropion—obesity	0.000141	0.0005	CcSEcCtD
Varenicline—Syncope—Bupropion—obesity	0.000141	0.000499	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—NR3C1—obesity	0.000141	0.00244	CbGpPWpGaD
Varenicline—Anorexia—Sibutramine—obesity	0.00014	0.000497	CcSEcCtD
Varenicline—Angina pectoris—Topiramate—obesity	0.00014	0.000496	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—BCHE—obesity	0.000139	0.00241	CbGpPWpGaD
Varenicline—Palpitations—Bupropion—obesity	0.000139	0.000492	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Orlistat—obesity	0.000138	0.00049	CcSEcCtD
Varenicline—Bronchitis—Topiramate—obesity	0.000138	0.000489	CcSEcCtD
Varenicline—Loss of consciousness—Bupropion—obesity	0.000138	0.000489	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—BCHE—obesity	0.000138	0.00239	CbGpPWpGaD
Varenicline—Abdominal discomfort—Topiramate—obesity	0.000138	0.000488	CcSEcCtD
Varenicline—Insomnia—Orlistat—obesity	0.000137	0.000487	CcSEcCtD
Varenicline—Hypotension—Sibutramine—obesity	0.000137	0.000487	CcSEcCtD
Varenicline—Cough—Bupropion—obesity	0.000137	0.000486	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—COMT—obesity	0.000136	0.00237	CbGpPWpGaD
Varenicline—Convulsion—Bupropion—obesity	0.000136	0.000482	CcSEcCtD
Varenicline—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	0.000136	0.00236	CbGpPWpGaD
Varenicline—Hypertension—Bupropion—obesity	0.000136	0.00048	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—HTR2A—obesity	0.000135	0.00234	CbGpPWpGaD
Varenicline—CHRNA7—Transmission across Chemical Synapses—GNB3—obesity	0.000134	0.00233	CbGpPWpGaD
Varenicline—Musculoskeletal discomfort—Sibutramine—obesity	0.000134	0.000475	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000134	0.00232	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—GNB3—obesity	0.000134	0.00232	CbGpPWpGaD
Varenicline—Dyspepsia—Orlistat—obesity	0.000134	0.000474	CcSEcCtD
Varenicline—Arthralgia—Bupropion—obesity	0.000134	0.000474	CcSEcCtD
Varenicline—Chest pain—Bupropion—obesity	0.000134	0.000474	CcSEcCtD
Varenicline—Myalgia—Bupropion—obesity	0.000134	0.000474	CcSEcCtD
Varenicline—Anxiety—Bupropion—obesity	0.000133	0.000472	CcSEcCtD
Varenicline—Insomnia—Sibutramine—obesity	0.000133	0.000471	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000133	0.00047	CcSEcCtD
Varenicline—Pollakiuria—Topiramate—obesity	0.000133	0.00047	CcSEcCtD
Varenicline—Erectile dysfunction—Topiramate—obesity	0.000132	0.000469	CcSEcCtD
Varenicline—Discomfort—Bupropion—obesity	0.000132	0.000468	CcSEcCtD
Varenicline—Decreased appetite—Orlistat—obesity	0.000132	0.000468	CcSEcCtD
Varenicline—Gastrointestinal disorder—Orlistat—obesity	0.000131	0.000465	CcSEcCtD
Varenicline—Dyspnoea—Sibutramine—obesity	0.000131	0.000464	CcSEcCtD
Varenicline—Photosensitivity reaction—Topiramate—obesity	0.000131	0.000464	CcSEcCtD
Varenicline—Fatigue—Orlistat—obesity	0.000131	0.000464	CcSEcCtD
Varenicline—Dry mouth—Bupropion—obesity	0.000131	0.000463	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—BCHE—obesity	0.000131	0.00227	CbGpPWpGaD
Varenicline—Somnolence—Sibutramine—obesity	0.000131	0.000463	CcSEcCtD
Varenicline—Weight increased—Topiramate—obesity	0.000131	0.000463	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—PPARG—obesity	0.00013	0.00226	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—BDNF—obesity	0.00013	0.00226	CbGpPWpGaD
Varenicline—Pain—Orlistat—obesity	0.00013	0.00046	CcSEcCtD
Varenicline—Hyperglycaemia—Topiramate—obesity	0.000129	0.000459	CcSEcCtD
Varenicline—Dyspepsia—Sibutramine—obesity	0.000129	0.000459	CcSEcCtD
Varenicline—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	0.000129	0.00224	CbGpPWpGaD
Varenicline—Oedema—Bupropion—obesity	0.000128	0.000454	CcSEcCtD
Varenicline—Infestation—Topiramate—obesity	0.000128	0.000454	CcSEcCtD
Varenicline—Infestation NOS—Topiramate—obesity	0.000128	0.000454	CcSEcCtD
Varenicline—Decreased appetite—Sibutramine—obesity	0.000128	0.000453	CcSEcCtD
Varenicline—Depression—Topiramate—obesity	0.000128	0.000452	CcSEcCtD
Varenicline—Infection—Bupropion—obesity	0.000127	0.000451	CcSEcCtD
Varenicline—Stevens-Johnson syndrome—Topiramate—obesity	0.000127	0.00045	CcSEcCtD
Varenicline—Gastrointestinal disorder—Sibutramine—obesity	0.000127	0.00045	CcSEcCtD
Varenicline—Shock—Bupropion—obesity	0.000126	0.000447	CcSEcCtD
Varenicline—Constipation—Sibutramine—obesity	0.000126	0.000445	CcSEcCtD
Varenicline—Pain—Sibutramine—obesity	0.000126	0.000445	CcSEcCtD
Varenicline—Nervous system disorder—Bupropion—obesity	0.000126	0.000445	CcSEcCtD
Varenicline—Thrombocytopenia—Bupropion—obesity	0.000125	0.000445	CcSEcCtD
Varenicline—Feeling abnormal—Orlistat—obesity	0.000125	0.000444	CcSEcCtD
Varenicline—Tachycardia—Bupropion—obesity	0.000125	0.000443	CcSEcCtD
Varenicline—Stomatitis—Topiramate—obesity	0.000125	0.000442	CcSEcCtD
Varenicline—Skin disorder—Bupropion—obesity	0.000124	0.000441	CcSEcCtD
Varenicline—Conjunctivitis—Topiramate—obesity	0.000124	0.000441	CcSEcCtD
Varenicline—Gastrointestinal pain—Orlistat—obesity	0.000124	0.00044	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL10—obesity	0.000124	0.00215	CbGpPWpGaD
Varenicline—Hyperhidrosis—Bupropion—obesity	0.000124	0.000439	CcSEcCtD
Varenicline—CHRNA6—Neuronal System—PRKCB—obesity	0.000123	0.00214	CbGpPWpGaD
Varenicline—Anorexia—Bupropion—obesity	0.000122	0.000433	CcSEcCtD
Varenicline—Feeling abnormal—Sibutramine—obesity	0.000121	0.000429	CcSEcCtD
Varenicline—Epistaxis—Topiramate—obesity	0.000121	0.000428	CcSEcCtD
Varenicline—Urticaria—Orlistat—obesity	0.000121	0.000428	CcSEcCtD
Varenicline—Gastrointestinal pain—Sibutramine—obesity	0.00012	0.000426	CcSEcCtD
Varenicline—Sinusitis—Topiramate—obesity	0.00012	0.000426	CcSEcCtD
Varenicline—Body temperature increased—Orlistat—obesity	0.00012	0.000425	CcSEcCtD
Varenicline—Abdominal pain—Orlistat—obesity	0.00012	0.000425	CcSEcCtD
Varenicline—Hypotension—Bupropion—obesity	0.00012	0.000424	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—SERPINE1—obesity	0.000117	0.00204	CbGpPWpGaD
Varenicline—Bradycardia—Topiramate—obesity	0.000117	0.000415	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL1B—obesity	0.000117	0.00203	CbGpPWpGaD
Varenicline—Urticaria—Sibutramine—obesity	0.000117	0.000414	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Bupropion—obesity	0.000117	0.000414	CcSEcCtD
Varenicline—Abdominal pain—Sibutramine—obesity	0.000116	0.000412	CcSEcCtD
Varenicline—Body temperature increased—Sibutramine—obesity	0.000116	0.000412	CcSEcCtD
Varenicline—Insomnia—Bupropion—obesity	0.000116	0.000411	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—NR3C1—obesity	0.000115	0.00199	CbGpPWpGaD
Varenicline—Hallucination—Topiramate—obesity	0.000114	0.000405	CcSEcCtD
Varenicline—Hypoaesthesia—Topiramate—obesity	0.000114	0.000405	CcSEcCtD
Varenicline—Dyspnoea—Bupropion—obesity	0.000114	0.000405	CcSEcCtD
Varenicline—Somnolence—Bupropion—obesity	0.000114	0.000404	CcSEcCtD
Varenicline—Urinary tract disorder—Topiramate—obesity	0.000113	0.000402	CcSEcCtD
Varenicline—Oedema peripheral—Topiramate—obesity	0.000113	0.000401	CcSEcCtD
Varenicline—Connective tissue disorder—Topiramate—obesity	0.000113	0.0004	CcSEcCtD
Varenicline—Dyspepsia—Bupropion—obesity	0.000113	0.0004	CcSEcCtD
Varenicline—Urethral disorder—Topiramate—obesity	0.000113	0.000399	CcSEcCtD
Varenicline—Hypersensitivity—Orlistat—obesity	0.000112	0.000397	CcSEcCtD
Varenicline—Decreased appetite—Bupropion—obesity	0.000111	0.000395	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—COMT—obesity	0.000111	0.00193	CbGpPWpGaD
Varenicline—Visual impairment—Topiramate—obesity	0.000111	0.000392	CcSEcCtD
Varenicline—Gastrointestinal disorder—Bupropion—obesity	0.000111	0.000392	CcSEcCtD
Varenicline—Fatigue—Bupropion—obesity	0.00011	0.000392	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—COMT—obesity	0.00011	0.00191	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—HTR2A—obesity	0.00011	0.00191	CbGpPWpGaD
Varenicline—CHRNA4—Transmission across Chemical Synapses—GNB3—obesity	0.00011	0.0019	CbGpPWpGaD
Varenicline—Pain—Bupropion—obesity	0.00011	0.000388	CcSEcCtD
Varenicline—Constipation—Bupropion—obesity	0.00011	0.000388	CcSEcCtD
Varenicline—Asthenia—Orlistat—obesity	0.000109	0.000386	CcSEcCtD
Varenicline—Erythema multiforme—Topiramate—obesity	0.000109	0.000385	CcSEcCtD
Varenicline—CHRNA3—Neuronal System—GNB3—obesity	0.000109	0.00189	CbGpPWpGaD
Varenicline—CHRNB2—Neuronal System—PRKCB—obesity	0.000108	0.00188	CbGpPWpGaD
Varenicline—Hypersensitivity—Sibutramine—obesity	0.000108	0.000384	CcSEcCtD
Varenicline—Pruritus—Orlistat—obesity	0.000107	0.000381	CcSEcCtD
Varenicline—Eye disorder—Topiramate—obesity	0.000107	0.000381	CcSEcCtD
Varenicline—Tinnitus—Topiramate—obesity	0.000107	0.00038	CcSEcCtD
Varenicline—Cardiac disorder—Topiramate—obesity	0.000107	0.000378	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—BCHE—obesity	0.000107	0.00185	CbGpPWpGaD
Varenicline—Feeling abnormal—Bupropion—obesity	0.000106	0.000374	CcSEcCtD
Varenicline—Asthenia—Sibutramine—obesity	0.000105	0.000374	CcSEcCtD
Varenicline—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	0.000105	0.00182	CbGpPWpGaD
Varenicline—Gastrointestinal pain—Bupropion—obesity	0.000105	0.000371	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—COMT—obesity	0.000104	0.00181	CbGpPWpGaD
Varenicline—Angiopathy—Topiramate—obesity	0.000104	0.000369	CcSEcCtD
Varenicline—Pruritus—Sibutramine—obesity	0.000104	0.000369	CcSEcCtD
Varenicline—Diarrhoea—Orlistat—obesity	0.000104	0.000368	CcSEcCtD
Varenicline—Immune system disorder—Topiramate—obesity	0.000104	0.000368	CcSEcCtD
Varenicline—Mediastinal disorder—Topiramate—obesity	0.000104	0.000367	CcSEcCtD
Varenicline—Chills—Topiramate—obesity	0.000103	0.000365	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—GNB3—obesity	0.000103	0.00179	CbGpPWpGaD
Varenicline—CHRNA3—Transmission across Chemical Synapses—PRKCB—obesity	0.000102	0.00177	CbGpPWpGaD
Varenicline—Urticaria—Bupropion—obesity	0.000102	0.000361	CcSEcCtD
Varenicline—Abdominal pain—Bupropion—obesity	0.000101	0.000359	CcSEcCtD
Varenicline—Body temperature increased—Bupropion—obesity	0.000101	0.000359	CcSEcCtD
Varenicline—Mental disorder—Topiramate—obesity	0.000101	0.000357	CcSEcCtD
Varenicline—Diarrhoea—Sibutramine—obesity	0.000101	0.000356	CcSEcCtD
Varenicline—Dizziness—Orlistat—obesity	0.0001	0.000356	CcSEcCtD
Varenicline—Erythema—Topiramate—obesity	0.0001	0.000354	CcSEcCtD
Varenicline—Malnutrition—Topiramate—obesity	0.0001	0.000354	CcSEcCtD
Varenicline—Flatulence—Topiramate—obesity	9.85e-05	0.000349	CcSEcCtD
Varenicline—Dysgeusia—Topiramate—obesity	9.79e-05	0.000347	CcSEcCtD
Varenicline—Dizziness—Sibutramine—obesity	9.72e-05	0.000344	CcSEcCtD
Varenicline—CHRNA7—Transmission across Chemical Synapses—PRKCB—obesity	9.67e-05	0.00168	CbGpPWpGaD
Varenicline—Back pain—Topiramate—obesity	9.67e-05	0.000343	CcSEcCtD
Varenicline—Vomiting—Orlistat—obesity	9.65e-05	0.000342	CcSEcCtD
Varenicline—Muscle spasms—Topiramate—obesity	9.61e-05	0.000341	CcSEcCtD
Varenicline—Rash—Orlistat—obesity	9.57e-05	0.000339	CcSEcCtD
Varenicline—Dermatitis—Orlistat—obesity	9.56e-05	0.000339	CcSEcCtD
Varenicline—Headache—Orlistat—obesity	9.51e-05	0.000337	CcSEcCtD
Varenicline—Hypersensitivity—Bupropion—obesity	9.44e-05	0.000335	CcSEcCtD
Varenicline—Vision blurred—Topiramate—obesity	9.42e-05	0.000334	CcSEcCtD
Varenicline—Tremor—Topiramate—obesity	9.37e-05	0.000332	CcSEcCtD
Varenicline—Vomiting—Sibutramine—obesity	9.34e-05	0.000331	CcSEcCtD
Varenicline—Ill-defined disorder—Topiramate—obesity	9.28e-05	0.000329	CcSEcCtD
Varenicline—Rash—Sibutramine—obesity	9.26e-05	0.000328	CcSEcCtD
Varenicline—Dermatitis—Sibutramine—obesity	9.26e-05	0.000328	CcSEcCtD
Varenicline—Anaemia—Topiramate—obesity	9.24e-05	0.000328	CcSEcCtD
Varenicline—Headache—Sibutramine—obesity	9.2e-05	0.000326	CcSEcCtD
Varenicline—Asthenia—Bupropion—obesity	9.19e-05	0.000326	CcSEcCtD
Varenicline—Agitation—Topiramate—obesity	9.19e-05	0.000326	CcSEcCtD
Varenicline—Pruritus—Bupropion—obesity	9.06e-05	0.000321	CcSEcCtD
Varenicline—Nausea—Orlistat—obesity	9.02e-05	0.00032	CcSEcCtD
Varenicline—Malaise—Topiramate—obesity	9.02e-05	0.00032	CcSEcCtD
Varenicline—Vertigo—Topiramate—obesity	8.98e-05	0.000318	CcSEcCtD
Varenicline—Syncope—Topiramate—obesity	8.97e-05	0.000318	CcSEcCtD
Varenicline—Palpitations—Topiramate—obesity	8.84e-05	0.000313	CcSEcCtD
Varenicline—Loss of consciousness—Topiramate—obesity	8.79e-05	0.000312	CcSEcCtD
Varenicline—Diarrhoea—Bupropion—obesity	8.76e-05	0.000311	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—MAPK8—obesity	8.74e-05	0.00152	CbGpPWpGaD
Varenicline—Nausea—Sibutramine—obesity	8.73e-05	0.000309	CcSEcCtD
Varenicline—Cough—Topiramate—obesity	8.73e-05	0.000309	CcSEcCtD
Varenicline—Convulsion—Topiramate—obesity	8.66e-05	0.000307	CcSEcCtD
Varenicline—Hypertension—Topiramate—obesity	8.63e-05	0.000306	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—COMT—obesity	8.51e-05	0.00148	CbGpPWpGaD
Varenicline—Myalgia—Topiramate—obesity	8.51e-05	0.000302	CcSEcCtD
Varenicline—Chest pain—Topiramate—obesity	8.51e-05	0.000302	CcSEcCtD
Varenicline—Arthralgia—Topiramate—obesity	8.51e-05	0.000302	CcSEcCtD
Varenicline—Anxiety—Topiramate—obesity	8.48e-05	0.000301	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—TNF—obesity	8.47e-05	0.00147	CbGpPWpGaD
Varenicline—Dizziness—Bupropion—obesity	8.47e-05	0.0003	CcSEcCtD
Varenicline—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.45e-05	0.0003	CcSEcCtD
Varenicline—Discomfort—Topiramate—obesity	8.41e-05	0.000298	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—GNB3—obesity	8.4e-05	0.00146	CbGpPWpGaD
Varenicline—Dry mouth—Topiramate—obesity	8.33e-05	0.000295	CcSEcCtD
Varenicline—Oedema—Topiramate—obesity	8.16e-05	0.000289	CcSEcCtD
Varenicline—Vomiting—Bupropion—obesity	8.14e-05	0.000289	CcSEcCtD
Varenicline—Infection—Topiramate—obesity	8.11e-05	0.000287	CcSEcCtD
Varenicline—Rash—Bupropion—obesity	8.08e-05	0.000286	CcSEcCtD
Varenicline—Dermatitis—Bupropion—obesity	8.07e-05	0.000286	CcSEcCtD
Varenicline—Shock—Topiramate—obesity	8.03e-05	0.000285	CcSEcCtD
Varenicline—Headache—Bupropion—obesity	8.02e-05	0.000284	CcSEcCtD
Varenicline—Nervous system disorder—Topiramate—obesity	8e-05	0.000284	CcSEcCtD
Varenicline—Thrombocytopenia—Topiramate—obesity	7.99e-05	0.000283	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL1B—obesity	7.98e-05	0.00139	CbGpPWpGaD
Varenicline—Tachycardia—Topiramate—obesity	7.96e-05	0.000282	CcSEcCtD
Varenicline—Skin disorder—Topiramate—obesity	7.93e-05	0.000281	CcSEcCtD
Varenicline—Hyperhidrosis—Topiramate—obesity	7.89e-05	0.00028	CcSEcCtD
Varenicline—CHRNA4—Transmission across Chemical Synapses—PRKCB—obesity	7.89e-05	0.00137	CbGpPWpGaD
Varenicline—CHRNA3—Neuronal System—PRKCB—obesity	7.81e-05	0.00136	CbGpPWpGaD
Varenicline—Anorexia—Topiramate—obesity	7.78e-05	0.000276	CcSEcCtD
Varenicline—Hypotension—Topiramate—obesity	7.63e-05	0.00027	CcSEcCtD
Varenicline—Nausea—Bupropion—obesity	7.61e-05	0.00027	CcSEcCtD
Varenicline—Musculoskeletal discomfort—Topiramate—obesity	7.44e-05	0.000264	CcSEcCtD
Varenicline—CHRNA7—Neuronal System—PRKCB—obesity	7.41e-05	0.00129	CbGpPWpGaD
Varenicline—Insomnia—Topiramate—obesity	7.38e-05	0.000262	CcSEcCtD
Varenicline—Dyspnoea—Topiramate—obesity	7.28e-05	0.000258	CcSEcCtD
Varenicline—Somnolence—Topiramate—obesity	7.25e-05	0.000257	CcSEcCtD
Varenicline—Dyspepsia—Topiramate—obesity	7.18e-05	0.000255	CcSEcCtD
Varenicline—Decreased appetite—Topiramate—obesity	7.09e-05	0.000251	CcSEcCtD
Varenicline—Gastrointestinal disorder—Topiramate—obesity	7.05e-05	0.00025	CcSEcCtD
Varenicline—Fatigue—Topiramate—obesity	7.04e-05	0.000249	CcSEcCtD
Varenicline—Pain—Topiramate—obesity	6.98e-05	0.000247	CcSEcCtD
Varenicline—Constipation—Topiramate—obesity	6.98e-05	0.000247	CcSEcCtD
Varenicline—CHRNB2—SIDS Susceptibility Pathways—IL6—obesity	6.84e-05	0.00119	CbGpPWpGaD
Varenicline—Feeling abnormal—Topiramate—obesity	6.72e-05	0.000238	CcSEcCtD
Varenicline—Gastrointestinal pain—Topiramate—obesity	6.67e-05	0.000237	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL1B—obesity	6.5e-05	0.00113	CbGpPWpGaD
Varenicline—Urticaria—Topiramate—obesity	6.48e-05	0.00023	CcSEcCtD
Varenicline—Abdominal pain—Topiramate—obesity	6.45e-05	0.000229	CcSEcCtD
Varenicline—Body temperature increased—Topiramate—obesity	6.45e-05	0.000229	CcSEcCtD
Varenicline—CHRNA4—Neuronal System—PRKCB—obesity	6.04e-05	0.00105	CbGpPWpGaD
Varenicline—Hypersensitivity—Topiramate—obesity	6.01e-05	0.000213	CcSEcCtD
Varenicline—Asthenia—Topiramate—obesity	5.86e-05	0.000208	CcSEcCtD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—TNF—obesity	5.79e-05	0.00101	CbGpPWpGaD
Varenicline—Pruritus—Topiramate—obesity	5.77e-05	0.000205	CcSEcCtD
Varenicline—Diarrhoea—Topiramate—obesity	5.58e-05	0.000198	CcSEcCtD
Varenicline—CHRNB2—Circadian rythm related genes—IL6—obesity	5.58e-05	0.00097	CbGpPWpGaD
Varenicline—Dizziness—Topiramate—obesity	5.4e-05	0.000191	CcSEcCtD
Varenicline—Vomiting—Topiramate—obesity	5.19e-05	0.000184	CcSEcCtD
Varenicline—Rash—Topiramate—obesity	5.15e-05	0.000182	CcSEcCtD
Varenicline—Dermatitis—Topiramate—obesity	5.14e-05	0.000182	CcSEcCtD
Varenicline—Headache—Topiramate—obesity	5.11e-05	0.000181	CcSEcCtD
Varenicline—Nausea—Topiramate—obesity	4.85e-05	0.000172	CcSEcCtD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—TNF—obesity	4.72e-05	0.00082	CbGpPWpGaD
Varenicline—CHRNA7—SIDS Susceptibility Pathways—IL6—obesity	4.67e-05	0.000811	CbGpPWpGaD
Varenicline—CHRNA4—SIDS Susceptibility Pathways—IL6—obesity	3.81e-05	0.000661	CbGpPWpGaD
